Clinical Trials
76 trialsROXI-CAT-I
Regeneron Pharmaceuticals
STAT-CAT
Brigham and Women's Hospital
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Memorial Sloan Kettering Cancer Center
MAGNOLIA
Anthos Therapeutics, Inc.
Apixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
Glioblastoma Remote Monitoring and Care - Research Protocol
Case Comprehensive Cancer Center
ROXI-CAT-II
Regeneron Pharmaceuticals
AVAJAK
University Hospital, Brest
AmiCARE
Shanghai Pulmonary Hospital, Shanghai, China
ASTER
Anthos Therapeutics, Inc.
DOAC
University of Vermont
CATIQ P3
Quercis Pharma AG
ASPIRE
Wake Forest University Health Sciences
VTE-POG
University of Vermont Medical Center
HEM-DOAC
Medical University of Gdansk
Implementing VTE Prevention in Ambulatory Cancer Care
University of Vermont
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
State University of New York - Upstate Medical University
LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology
Massachusetts General Hospital
MYELAXAT
University Hospital, Grenoble
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
Medical University of South Carolina
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
PREVENT-GU
Ottawa Hospital Research Institute
TRIM-Line
Ottawa Hospital Research Institute
CARAVAGGIO
Fadoi Foundation, Italy
STREAM-Line
Ottawa Hospital Research Institute
Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
LEO Pharma
A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery
Beijing Friendship Hospital
AIRPORT-MPN
Ottawa Hospital Research Institute
ROSIE
Radboud University Medical Center
WAVe
Ottawa Hospital Research Institute
Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients
Nanfang Hospital, Southern Medical University
CANVAS
Alliance Foundation Trials, LLC.
APEX
Alexion Pharmaceuticals, Inc.
PROVE
Assistance Publique - Hôpitaux de Paris
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
Duke University
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
McMaster University
Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
University of Utah
VALERIA
Science Valley Research Institute
Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients
AIO-Studien-gGmbH
Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs
Instituto de Investigacion Sanitaria La Fe
PROSPECT
Hospices Civils de Lyon
PREVENTER
Johns Hopkins University
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
University of Colorado, Denver
DOMICA
Poitiers University Hospital
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Dana-Farber Cancer Institute
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
Fred Hutchinson Cancer Center
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants
Janssen Research & Development, LLC
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
Huazhong University of Science and Technology
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
Case Comprehensive Cancer Center